Advay Bhatt, MD
Clinical Cardiac Electrophysiology · Paramus, NJNPI 1598713737
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.5%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by The Scottcare Corporation at 40.4% of the total. Reporting peaked in 2023 at $18,321 and has fallen 95.8% since, to $767 in 2025.
Across 187 payments — averaging $225.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- The Scottcare Corporation$17K
- Medtronic$15K
- Boston Scientific$5K
- Philips North America LLC$3K
- Abbott$1K
- Cardiva Medical, Inc.$521
- plus $847 from 10 others
Across 12 payments — averaging $822.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$10K
What the payments were for
- Consulting fees$17,50042%
- Speaking & faculty fees$13,70033%
- Travel & lodging$3,7459%
- Food & beverage$7,18517%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| The Scottcare Corporation | 2 | $17,000 |
| Medtronic(2 entities) | 43 | $14,577 |
| Boston Scientific | 78 | $5,061 |
| Philips North America LLC | 10 | $2,944 |
| Abbott | 17 | $1,180 |
| Cardiva Medical, Inc. | 2 | $521 |
| Biosense Webster, Inc. | 4 | $278 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 15 | $263 |
| Atricure, Inc. | 1 | $84 |
| Sanofi-aventis U.S. LLC | 4 | $57 |
| Johnson & Johnson | 4 | $49 |
| E.r. Squibb & Sons, L.L.C. | 3 | $41 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Kestra Medical Technology Services, Inc. | 1 | $20 |
| Amgen | 1 | $15 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TightRail$2,346
- AVEIR$757
- EVERA MRI XT DR SURESCAN$714
- Watchman$515
- Vascular Closure Device$500
- Rhythmia Mapping System$441
- COBALT DR MRI SURESCAN$333
- GENERAL - THERAPIES$307
- LUX-DX$271
- WATCHMAN Access System$246
- AURORA EV-ICD MRI SURESCAN$171
- LINQ II$161
- Bridge$150
- CVX-300$150
- RHYTHMIA$149
- ARCTIC FRONT ADVANCE$149
- Farapulse$128
- Micra$127
- Carto 3$124
- WATCHMAN FLX$123
How this compares
$42,130 in reported general payments places this provider in the 80th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
See all clinical cardiac electrophysiology providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 133 | $139,407 |
| XareltoRivaroxaban | 43 | $55,792 |
| MultaqDronedarone Hcl | 29 | $49,994 |
| EntrestoSacubitril/Valsartan | 11 | $20,277 |
| Dofetilide | 19 | $4,226 |
| Ranolazine ErRanolazine | 22 | $3,991 |
| Flecainide Acetate | 68 | $2,540 |
| Metoprolol Succinate | 158 | $2,384 |
| Amiodarone Hcl | 81 | $1,608 |
| Nebivolol Hcl | 23 | $810 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 19 | $713 |
| Atorvastatin Calcium | 14 | $65 |
| Pantoprazole Sodium | 17 | $40 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $13 | $139,407133 claims |
| Johnson & JohnsonXarelto | $49 | $55,79243 claims |
| Sanofi-aventis U.S. LLCMultaq | $57 | $49,99429 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 102 clinical cardiac electrophysiology providers in New Jersey.
Other clinical cardiac electrophysiology in Paramus
- Suneet MittalParamus$722K
- Benjamin D SouzaCherry Hill$741K
- George MarkHaddon Heights$312K
- Raffaele CorbisieroBrowns Mills$135K
- Emad AzizNewark$112K
- Marc RoelkeWest Orange$110K
- Arjun TheerthamParlin$102K
- Michael LinkGalloway$96K
- Grant SimonsEnglewood$93K
- Jonathan SteinbergRidgewood$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.